Effect of polyethylene glycol-modified adenosine deaminase (PEG-ADA) therapy in two ADA-deficient children: measurement of erythrocyte deoxyadenosine triphosphate as a useful tool.

Suppr

超能文献

作者信息

Bory C, Boulieu R, Souillet G, Chantin C, Guibaud P, Hershfield M S

机构信息

Laboratoire de Biochimie, Hôpital Debrousse, Lyon, France.

出版信息

Adv Exp Med Biol. 1991;309A:173-6. doi: 10.1007/978-1-4899-2638-8_39.

DOI:10.1007/978-1-4899-2638-8_39

PMID:1789201

Abstract

摘要

相似文献

Effect of polyethylene glycol-modified adenosine deaminase (PEG-ADA) therapy in two ADA-deficient children: measurement of erythrocyte deoxyadenosine triphosphate as a useful tool.

Adv Exp Med Biol. 1991;309A:173-6. doi: 10.1007/978-1-4899-2638-8_39.

Long-term efficacy of enzyme replacement therapy for adenosine deaminase (ADA)-deficient severe combined immunodeficiency (SCID).腺苷脱氨酶（ADA）缺乏的重症联合免疫缺陷（SCID）的酶替代疗法的长期疗效。

Clin Immunol. 2005 Nov;117(2):133-43. doi: 10.1016/j.clim.2005.07.006. Epub 2005 Aug 22.

[Polyethylene glycol-adenosine deaminase: a new adenosine deaminase deficiency therapy. Value of deoxyadenosine triphosphate determination for therapeutic monitoring].

Therapie. 1991 Jul-Aug;46(4):323-6.

T lymphocyte ontogeny in adenosine deaminase-deficient severe combined immune deficiency after treatment with polyethylene glycol-modified adenosine deaminase.聚乙二醇修饰的腺苷脱氨酶治疗后腺苷脱氨酶缺陷型重症联合免疫缺陷中的T淋巴细胞个体发生

J Clin Invest. 1993 Aug;92(2):596-602. doi: 10.1172/JCI116626.

Enzyme replacement therapy of adenosine deaminase deficiency with polyethylene glycol-modified adenosine deaminase (PEG-ADA).聚乙二醇修饰的腺苷脱氨酶（PEG-ADA）用于腺苷脱氨酶缺乏症的酶替代疗法。

Immunodeficiency. 1993;4(1-4):93-7.

Comparison of red cell transfusion and polyethylene glycol-modified adenosine deaminase therapy in an adenosine deaminase-deficient child: measurement of erythrocyte deoxyadenosine triphosphate as a useful tool.腺苷脱氨酶缺乏患儿红细胞输血与聚乙二醇修饰腺苷脱氨酶治疗的比较：以红细胞三磷酸脱氧腺苷测定作为一种有用工具

Pediatr Res. 1990 Aug;28(2):127-30. doi: 10.1203/00006450-199008000-00010.

Enzyme replacement therapy with polyethylene glycol-adenosine deaminase in adenosine deaminase deficiency: overview and case reports of three patients, including two now receiving gene therapy.聚乙二醇化腺苷脱氨酶用于腺苷脱氨酶缺乏症的酶替代疗法：概述及三例患者病例报告，其中两例患者目前正在接受基因治疗。

Pediatr Res. 1993 Jan;33(1 Suppl):S42-7; discussion S47-8. doi: 10.1203/00006450-199305001-00236.

Formation and degradation of deoxyadenosine nucleotides in inherited adenosine deaminase deficiency.遗传性腺苷脱氨酶缺乏症中脱氧腺苷核苷酸的形成与降解

Biosci Rep. 1982 May;2(5):303-14. doi: 10.1007/BF01115116.

[Treatment of adenosine deaminase deficiency with adenosine deaminase combined with polyethylene glycol].用聚乙二醇结合的腺苷脱氨酶治疗腺苷脱氨酶缺乏症

Arch Fr Pediatr. 1992 Apr;49(4):339-43.

A 9-yr evaluation of carrier erythrocyte encapsulated adenosine deaminase (ADA) therapy in a patient with adult-type ADA deficiency.对一名成年型腺苷脱氨酶（ADA）缺乏症患者进行载体红细胞包裹的腺苷脱氨酶（ADA）治疗的9年评估。

Eur J Haematol. 2007 Oct;79(4):338-48. doi: 10.1111/j.1600-0609.2007.00927.x. Epub 2007 Aug 3.

引用本文的文献

Sustained Delivery of the Antiviral Protein Griffithsin and Its Adhesion to a Biological Surface by a Silk Fibroin Scaffold.通过丝素蛋白支架实现抗病毒蛋白格里菲斯菌素的持续递送及其在生物表面的粘附

Materials (Basel). 2023 Aug 9;16(16):5547. doi: 10.3390/ma16165547.

Reservoir-Style Polymeric Drug Delivery Systems: Empirical and Predictive Models for Implant Design.储库型聚合物药物递送系统：植入物设计的经验模型与预测模型

Pharmaceuticals (Basel). 2022 Oct 3;15(10):1226. doi: 10.3390/ph15101226.

Nanotechnology: a focus on nanoparticles as a drug delivery system.纳米技术：聚焦于作为药物递送系统的纳米颗粒

J Neuroimmune Pharmacol. 2006 Sep;1(3):340-50. doi: 10.1007/s11481-006-9032-4.

Modification of Escherichia coli B glutathione synthetase with polyethylene glycol for clinical application to enzyme replacement therapy for glutathione deficiency.用聚乙二醇修饰大肠杆菌B谷胱甘肽合成酶，用于谷胱甘肽缺乏症酶替代疗法的临床应用。

Clin Diagn Lab Immunol. 1996 Nov;3(6):663-8. doi: 10.1128/cdli.3.6.663-668.1996.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验